What is the maximum recommended dose of agomelatine for adults with major depressive disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Agomelatine Maximum Dose

The maximum recommended dose of agomelatine for adults with major depressive disorder is 50 mg once daily, taken at bedtime.

Dosing Algorithm

Starting dose: Begin with agomelatine 25 mg once daily at bedtime 1, 2, 3.

Dose escalation: If insufficient improvement is observed after 2 weeks of treatment at 25 mg, increase to 50 mg once daily at bedtime 1, 2.

Maximum dose: 50 mg/day is the established maximum therapeutic dose 1, 2, 3.

Evidence Supporting the 50 mg Maximum

A placebo-controlled dose-finding study directly compared three agomelatine regimens (10 mg, 25 mg, and 25-50 mg flexible dosing) in 549 patients with major depressive disorder 1. The study demonstrated:

  • 10 mg showed minimal efficacy with a placebo difference of only 2.46 points on HAM-D₁₇ (p=0.001)
  • 25 mg showed robust efficacy with a placebo difference of 4.71 points (p<0.0001)
  • 25-50 mg flexible dosing showed similar efficacy to fixed 25 mg with a placebo difference of 4.92 points (p<0.0001)

Critically, there was no additional benefit demonstrated above 50 mg, and the study established 25 mg as the threshold therapeutic dose 1.

Another pivotal trial specifically evaluated fixed doses of 25 mg versus 50 mg 2. The 50 mg dose provided statistically significant improvement compared to placebo (treatment difference 2.5 points, p=0.004), while 25 mg did not reach significance in this particular study (p=0.505). However, the 50 mg dose was associated with clinically notable transient aminotransferase elevations in 4.5% of patients 2.

Clinical Considerations

Liver monitoring is essential: Given the hepatotoxicity risk, particularly at 50 mg, liver function tests should be monitored before treatment initiation and periodically during treatment, especially when using the maximum dose 2.

Timing matters: Agomelatine should be taken at bedtime due to its melatonergic mechanism of action, which helps resynchronize circadian rhythms 3.

No evidence for exceeding 50 mg: Multiple studies consistently show that 50 mg represents the ceiling dose for efficacy, with no data supporting higher doses 1, 2, 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.